KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Share-based Compensation (2016 - 2026)

Medtronic (MDT) has disclosed Share-based Compensation for 13 consecutive years, with $94.0 million as the latest value for Q1 2026.

  • Quarterly Share-based Compensation fell 4.08% to $94.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $451.0 million through Jan 2026, up 4.88% year-over-year, with the annual reading at $429.0 million for FY2025, 9.16% up from the prior year.
  • Share-based Compensation hit $94.0 million in Q1 2026 for Medtronic, down from $182.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $182.0 million in Q4 2025 to a low of $62.0 million in Q3 2022.
  • Historically, Share-based Compensation has averaged $99.4 million across 5 years, with a median of $86.0 million in 2025.
  • Biggest YoY gain for Share-based Compensation was 20.0% in 2022; the steepest drop was 10.14% in 2022.
  • Year by year, Share-based Compensation stood at $137.0 million in 2022, then grew by 6.57% to $146.0 million in 2023, then increased by 8.9% to $159.0 million in 2024, then increased by 14.47% to $182.0 million in 2025, then plummeted by 48.35% to $94.0 million in 2026.
  • Business Quant data shows Share-based Compensation for MDT at $94.0 million in Q1 2026, $182.0 million in Q4 2025, and $86.0 million in Q3 2025.